Golan Omicron in the US and the approval of the second anti-Corona pill
The pill was approved on the eve of the New Year, while Joe Biden’s government’s plans to overcome Covid 19 disease in the country were not successful, and also one day after Pfizer’s “Paxlovid” pill was approved. It is Merck, which was first approved by the UK in November.
Less than three weeks after the first case of the Omicron strain was identified in the United States, the new strain has now been approved in all 50 states, surpassing the Delta strain as the predominant strain, according to NBC News. Is.
Following the identification of the Omicron strain in the United States, several states, including New York, Maine and Washington, set a seven-day average for Covid-19 this week.
The Associated Press claims that Merck’s Molnopiravir anti-coronary pills will be the preferred choice for patients with coronary heart disease because of their lesser side effects than Merck pills.
According to the report, Merck’s ability to prevent the severe form of the Corona virus is far less than the company’s initial announcements. The pill’s label also warns of serious safety issues, including the possibility of birth defects.
The US Food and Drug Administration has prescribed Merck tablets for adults who have a positive coronary test and have severe early symptoms. High-risk groups include the elderly and people with conditions such as obesity and heart disease.
The US Food and Drug Administration has announced that Merck, a drug called “Mulnopiravir”, will have a warning about its use during pregnancy. Women of childbearing potential should take birth control pills during and a few days after treatment, while men should take birth control pills for at least three months after taking their last pill.
The US Food and Drug Administration has already approved the first Corona antiviral pill for home use in the midst of the crisis.
Paxlovid pills were approved as US health officials warned of a tsunami of new infections due to the omicron corona strain, which could put pressure on hospitals.
According to US media reports, Paxlovid is Pfizer’s pill, which the company claims offers a faster and cheaper way to treat coronary heart disease, while all previous coronary heart disease drugs were prescribed by injection.
The Associated Press claims that Pfizer pills have mild side effects but are effective in treating coronary heart disease and prevent up to 90% of hospitalizations and possible death of coronary heart disease patients with severe symptoms.
“The effectiveness of this pill is high and its side effects are low and it is prescribed orally,” said Dr. Gregory Poland of the Mayo Clinic. This drug reduces the risk of hospitalization and death by 90% among high-risk groups, which is very significant.
With the rise of the Omicron Corona virus in the United States, President Joe Biden has vowed to counter the strain during the harsh American winter by allocating 500 million free coronas, increasing hospital support and expanding vaccination plans.
Biden has been forced to make major changes to its plan to fight the coronavirus in the winter due to the rapid spread of the omicron strain in the United States.
The White House said in a statement that Biden’s plan is based on the US government purchasing 500 million rapid corona virus test kits and sending them to Americans free of charge from January. Individuals must register on a website to receive these corona test kits, and then the government will send the kits to their address.
The New York Times reported that Biden’s plan was aimed at countering the spread of the omicron strain in the United States.
US health experts and officials warn that the Secretary-General of the World Health Organization also warned at a press conference yesterday about the rapid spread of a new study on omicrons, stressing that even vaccinated and newly vaccinated people Improved from Covid-19 may also cause omicron.
On November 26, the World Health Organization declared the omicron strain the fifth most troubling type of coronavirus. The new strain, first identified in South Africa, has caused concern in many countries and has been identified in more than 89 countries so far, according to the World Health Organization.
.